** Shares of Australia's Tetratherix TTX.AX rise as much as 15.3% to A$3.320 on trading debut, compared with their IPO offer price of A$2.88 per share
** Firm lists on the ASX to accelerate development of its polymer platform technology, Tetramatrix
** Co raised A$25 million ($16.33 million) in its IPO, valuing it at A$145 million
** TTX has developed a proprietary fluid matrix that is invisible to the body and does not induce any foreign bodily reaction to evolve regenerative medicine and targeted therapeutic delivery
** TTX shares pare early surge to climb 0.7% at A$2.90, compared with 0.4% gain in the ASX200 benchmark index .AXJO
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。